The Jun protein is a transcription factor of the AP-1 complex, and it is concentrated in the cell nucleus. While the cellular Jun protein is transported into the nucleus in a cell-cycle-independent fashion, the oncogenic viral version of the protein translocates into the nucleus most rapidly during the G2 phase of the cell cycle and only slowly during G, and S phases. This cell cycle dependence of nuclear transport has been mapped to the cysteine to serine mutation in the carboxylterminal portion of viral Jun. We have identified a complex nuclear translocation signal located in the bask region of viral Jun. This signal has the sequence ASKSRKRKL. A peptide of this sequence synthesized in vitro and conjugated to IgG can mediate cell-cycle-dependent translocation ofthe microinjected conjugate from the cytoplasm into the nucleus. The nuclear translocation signal has two functional domains. The pentapeptide RKRKL is sufficient as a cell-cycle-independent nucear address. The entire signal is needed for cell-cycledependent nuclear translocation. The amino-terminal tetrapeptide contains the cysteine to serine substitution responsible for cell cycle dependence. Deletion analysis of the Jun protein suggests that the nuclear translocation signal identified In the badc region is required for nuclear translocation of Jun and may be the only such signal in the Jun molecule.
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The Jun protein is a member of the AP-1 transcription factor family (1, 2) . It dimerizes with itself, with other AP-1 proteins, or with transcriptional regulators of the ATF and steroid receptor families (reviewed in ref. 3 ). These dimers bind to specific enhancer DNA sequences and regulate transcription positively or negatively (3) . Immunofluorescent staining shows Jun concentrated in the cell nucleus (4) . We describe here the identification ofa nuclear localization signal (NLS) in Jun and show that in the oncogenic viral version of Jun (v-Jun) the function of this nuclear addressing peptide is modulated by an amino acid substitution that makes nuclear translocation ofv-Jun cell cycle dependent, while cellular Jun (c-Jun) enters the nucleus at approximately constant rates throughout the cell cycle. We also show that the NLS of Jun, conjugated to an unrelated protein, can effect the translocation of that protein into the nucleus. In the case of the v-Jun NLS, this translocation of the heterologous protein becomes cell cycle dependent. The NLS of Jun described here is located in the highly basic DNA contact domain of the molecule, and it appears to be the only NLS of Jun. MATERIALS AND METHODS Synchronization. Infected or uninfected control chicken embryo fibroblasts (CEF) were grown in medium F10 containing 5x concentrations of vitamins and folic acid and supplemented with 10% fetal calf serum and 4% chicken serum (CLM). Cells were arrested in Go by reducing the fetal calf serum and chicken serum concentrations to 1% and 0.4%, respectively, for 3 days. Change to CLM was followed by DNA synthesis in more than 90% of the cells 8 hr later. In a second method of synchronization, GO-arrested cells were exposed to aphidicolin at 10 ,ug/ml in CLM, which resulted in arrest at the G1/S boundary. Cells were released from the aphidicolin block by washing with CLM and entered S, which lasted 6 hr. Cytokinesis started 3-4 hr after S. with PBS and twice with 10 mM diethylamine buffer (pH 9.5) containing 0.5 mM MgCl2 and incubated in 0.5 ml of p-nitrophenyl phosphate at 1 mg/ml in the diethylamine buffer for 4 hr at room temperature. The reaction was stopped by addition of 0. Peptide-IgG conjugates at 5 mg/ml in PBS were injected into the cytoplasm of 300-500 cells grown on coverslips. During microinjections, cells were kept in F10 medium supplemented with 5% calf serum (GM) at room temperature. The microinjected cells on coverslips were transferred to fresh GM at 37°C and incubated in a CO2 incubator at 37°C. Cells were washed with cold PBS and then fixed with formaldehyde. Microinjected rabbit IgG was detected by direct immunofluorescence using goat anti-rabbit IgG antibody conjugated to fluorescein isothiocyanate.
Immunoblotting. Cells were harvested by scraping with a rubber policeman and lysed at 107 cells per ml in an extraction buffer consisting of 10 mM Tris HCl (pH 7.4), 10 mM NaCI, 3 mM MgCl2 and 0.1% Nonidet P-40 at 0°C. Crude nuclei were prepared by using a glass homogenizer. Cytoplasmic and nuclear fractions were obtained by centrifugation at 10,000 X g for 30 min.
Immunoblotting was carried out by the procedure of Towbin et al. (7) . Proteins were separated by SDS/PAGE (8) 
Short DNAs of 380 base pairs (bp) for construct A9 (cf. Fig.  9 ) and 340 bp for construct B2 were produced by using VO-118 and VO-123, respectively, as plus-strand primers and VO-119 as minus-strand primer. The DNAs were digested with Nco I and HindIII and then substituted for the Nco I-HindIII region coding for the carboxyl terminus of v-Jun in pA05-5-2. For making the internal deletion mutant C3, two short DNAs of 330 and 360 bp were produced by using combinations ofprimers VO-119 and VO-126 and VO-127 and VO-128. The two DNAs were digested with Eag I, mixed, and ligated. The resulting DNA of 650 bp was digested with Nco I and HindIII and substituted for the Nco I-HindIII region of pA05-5-2. GVJ100 was the chimeric construct of VJO (10) and VJ100 [obtained from L. S. Havarstein and I. M. Morgan (11) ] using the Nco I site of the jun coding region. Cloning procedures for the expression vector RCAS and transfection of plasmid DNAs to cells were performed by methods previously described (12, 13) . (Fig. 1A) . This heterogeneity persisted in clonal cultures derived from single ASV-17-infected CEF and could therefore not be caused by differences in viral gene expression between proviral integration sites. Immunofluorescent staining did not reveal cytoplasmic Jun protein, possibly because its broader distribution kept it below detectable levels or because it was inaccessible to the monoclonal antibody used. However, immunoblots of CEF lysates, separated into nuclear and cytoplasmic fractions, clearly showed that Jun protein occurred also in the cytoplasm (Fig. 2) .
Synchronization Jun-specific nuclear fluorescence was cell cycle dependent: it was lowest in G1 (90% of nuclei 1-2+, 0o 4+) and highest in G2 (>80o of nuclei 4+). The same observation was made on CEF infected with the v-Jun-expressing retrovirus vector RCAS VJ-0 (10). In contrast to v-Jun, c-Jun did not show this strong cell-cycle-dependent variation. CEF infected with the chicken c-Jun-expressing retrovirus vector RCAS CJ-3 showed c-Jun-specific nuclear immunofluorescent staining of an intensity that was approximately the same in all nuclei in nonsynchronized cultures (Fig. 1B) . Amounts of endogenous c-Jun as determined by immunoblotting were too small to contribute to the immunofluorescent staining under these conditions (data not shown).
Quantitative measurements of the cell-cycle-dependent nuclear-cytoplasmic distribution of Jun were obtained with the ELISA technique using CEF fractionated in situ (5) . Fig.  3A shows the results for CEF infected with RCAS VJ-0 and synchronized by serum starvation. At various times after addition of serum, nuclei were prepared and their v-Jun contents were compared to those of whole cells. While v-Jun in whole cells increased during Go to G1, nuclear translocation took place mainly during S to G2. CEF overexpressing chicken c-Jun from the retrovirus vector RCAS CJ-3 did not show this delay in nuclear translocation of Jun (Fig. 3B) . In c-Jun-overexpressing cells the amounts of c-Jun in nuclei paralleled those of c-Jun in whole cells. Synchronization with aphidicolin gave the same results for v-Jun and c-Jun as did serum starvation. Fig. 3 also shows that the time course of total c-Jun synthesis after serum stimulation is the same for VJ-0-and CJ-3-infected CEF, as would be expected because both constructs are driven by the same long terminal repeat (14) . To determine which of these differences was responsible for the cell-cycle-dependent nuclear translocation of Jun, we constructed a series of RCAS-Jun expression vectors that carried these changes singly or in combination. CEF were transfected with these constructs, and cell cycle dependency of nuclear translocation was determined by immunofluorescence of clonal cell populations and by ELISA measurements of nuclei and whole cells after serum synchronization (Fig. 4) . Cell These peptides were synthesized and conjugated by covalent linkage to rabbit IgG. Solutions ofthese conjugates were then microinjected at 1-3 pg in 0.5 pl into the cytoplasm of CEF. One hour after injection the cells were immunofluorescently stained with an IgG-specific serum. The PEP4-conjugated IgG was effectively translocated into the nucleus. The PEP1 and PEP5 conjugates remained cytoplasmic, as did nonconjugated IgG (Fig. 5) . Translocation of the PEP4 conjugate could be abolished by coinjection of an excess of free PEP4. To test for possible cell cycle dependence of the IgG nuclear translocation, the PEP4 conjugate was microinjected into CEF synchronized by serum or aphidicolin, and nuclear translocation was assessed during various stages of the cell cycle by IgG-specific immunofluorescence after incubation at 37TC for 15 min (Fig. 6 ). The rate of nuclear translocation for PEP4-IgG was negligible during Go, slow during G1 and S, and rapid during G2. A conjugate of IgG and the NLS of the simian virus 40 T (tumor) antigen (PKKKRKV) also was translocated into the nucleus but not in a cell-cycledependent manner (data not shown). We Mapping of the NLS in PEP4. The PEP4 peptides with terminal deletions shown in the figure were conjugated to rabbit IgG and microinjected into serum-synchronized CEF, and the conjugates were localized by immunofluorescence. Each peptide also contained the sequence CGG at the amino terminus and GG at the carboxyl terminus, except for PEP4 and PEP4-Glu C, which contained a single cysteine residue at the amino terminus. The GG sequence at the termini served as a spacer, and the sulfhydryl group of the cysteine was needed for coupling with the crosslinker, maleimidobenzoic acid N-hydroxysuccinimide ester. 8 . Mapping of the cell cycle dependence of nuclear translocation. The deletion peptides shown in the figure were conjugated to rabbit IgG and microinjected into serum-synchronized CEF, and the conjugates were localized 15 min after injection to reveal cell cycle dependence. Peptide D4 also contained the sequence CGG at the amino terminus. Peptide DO-6 contained the sequence GG at the carboxyl terminus and a single cysteine residue at the amino terminus. See also legend to Fig. 7 .
of Jun contains a cell-cycle-regulated NLS that can function when conjugated to an unrelated protein.
Cell using an antibody directed against Jun PEP2 (15) . The results of these tests (Fig. 9) show that the NLS of PEP4 is essential for nuclear localization of Jun and may be the only NLS of the Jun protein. Deletions outside this region did not affect nuclear translocation, while the deletion of the PEP4 region resulted in cytoplasmic accumulation of Jun.
DISCUSSION
Nuclear entry ofproteins results from a specific translocation process (reviewed in refs. [16] [17] [18] . The protein to be transported contains a short stretch of amino acids acting as specific NLS. This signal sequence is recognized by NLSbinding proteins (NBPs) that appear to function as adaptor molecules of the nuclear transport machinery. In a first, ATP-independent, step of nuclear translocation, they effect the movement of the protein to the cytoplasmic side of the nuclear pore complex (NPC). Transit through the NPC and entry into the nuclei are energy dependent. The NLS identified in Jun is similar to the prototypical one of the simian virus 40 large T (tumor) antigen in its high content of basic residues. It mediates nuclear transport that is ATP dependent . Furthermore, the nuclear transport is inhibited by wheat germ agglutinin, as is the nuclear localization of other proteins, probably reflecting the modification of nucleoporin proteins by 0-linked N-acetylglucosamine. Unlike nuclear translocation of many proteins including c-Jun, that of v-Jun is cell cycle regulated. Amino acids adjacent to the amino terminus of the plain NLS are able to modulate its function. We speculate that this modulation either affects the initial interaction between the Jun NLS with NBP or acts at a later stage, determining passage through the NPC. The mutation in v-Jun that induces cell cycle dependence generates a possible phosphorylation site within a consensus sequence for protein kinase C. This site may be a target of cell-cycle-specific phosphorylation, but other modifications of the v-Jun NLS cannot be ruled out. Cell-cycle-dependent nuclear translocation has recently been reported for the yeast transcription factor SWI 5 (19, 20) . It is controlled by the CDC28 kinase. For the simian virus 40 T antigen, the rate of nuclear translocation depends on phosphorylation oftwo serines near the NLS by casein kinase II (21) . Another mechanism by which nuclear entry can be controlled is the masking of the NLS by a cytoplasmic protein. The NLS of the glucocorticoid receptor appears to be silenced in the absence of the hormone by an interaction of the receptor and the heat shock protein hsp90 (22) . Factor NF-KB is kept in the cytoplasm by binding to IKB (23) . It is striking that by immunofluorescent staining in the absence of detergents Jun cannot be convincingly detected in the cytoplasm, possibly because the epitope reacting with the monoclonal antibody is masked by the association with other proteins that could affect nuclear transport. The cysteine to serine substitution in v-Jun at position 248 is responsible for making the entry ofJun into the nucleus cell cycle dependent. The same substitution has also been shown to affect a redox control mechanism that regulates DNA binding of Jun (24) . c-Jun binds to DNA effectively only if the cysteine at position 248 is reduced. The cysteine to serine mutation at this position relieves DNA binding from redox control. Recent studies in our laboratory have also shown that this same mutation alone is sufficient for converting the nontumorigenic c-Jun protein into one that induces tumors in the animal, although the mutation has only a slight effect on transformation in CEF cell culture (ref. 15 ; I. M. Morgan, L. S. Havarstein, and P.K.V., unpublished data). The altered regulation in nuclear entry of v-Jun may therefore be related to its tumor-inducing capacity.
